Rosuvastatin has possible interactions with alcohol, some other drugs, and certain supplements. Examples include antacids ...

Researchers Find Cholesterol-Lowering Drugs Have No Effect on Kidney Function Jan. 27, 2025 — Statins, a class of cholesterol-lowering drugs, have no effect on kidney function, a research team has ...

Higher dietary cholesterol intake is linked to an increased risk of myocardial infarction among U.S. veterans, reinforcing ...

His colleagues’ use of Wegovy and Zepbound reminds him of the use of statins, drugs that lower cholesterol, in their early days. Cardiologists, who were most familiar with the consequences of ...

However, many current statins have major limitations. Moreover, innovative treatments need to address non-LDL-C residual risk (which may be marked by high triglycerides, low HDL-C concentrations ...

Background: Statins are generally well tolerated, but some patients discontinue therapy secondary to adverse effects. Dosing a statin (rosuvastatin) every other day (EOD) may provide significant ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...

Cholesterol-lowering statin drugs could be available to millions more patients in the UK, if new recommendations from health technology assessment (HTA) organisation NICE are implemented.

In summary, enalapril significantly mitigated multiple pathological markers associated with aging, including lipid droplets, amyloid, glycogen deposition, and fibrosis, in the brain, kidneys, liver, ...

The rising trend in health and lifestyle related problems in the world warrants us to be well informed and health-conscious of the latest happenings in this field. Medindia offers a freely ...

Researchers have reported on the ... Cancer Biologists Discover a New Mechanism for an Old Drug Oct. 7, 2024 — Doctors have long believed the cancer drug 5-fluorouracil works by damaging the ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...